alexa Japanese experience with micropremies weighing less than 600 grams born between 1984 to 1993.
Bioinformatics & Systems Biology

Bioinformatics & Systems Biology

Journal of Health & Medical Informatics

Author(s): Oishi M, Nishida H, Sasaki T, Oishi M, Nishida H, Sasaki T, Oishi M, Nishida H, Sasaki T, Oishi M, Nishida H, Sasaki T

Abstract Share this page

Abstract The viability limit defined by the Japanese Eugenic Protection Act was amended from 24 to 22 completed weeks of gestation in 1991. To testify if the amendment is appropriate, we conducted a survey on the mortality and morbidity rates of infants less than 600 g born in Japan between 1984 to 1993. Questionnaires were mailed to 205 hospitals with neonatal intensive care units (NICUs) and 165 (80\%) responded. Of 1655 infants <600 g birth weight and admitted to the NICUs included in this survey, 457 (28\%) survived to hospital discharge. The survival rates of infants born <24 weeks and >==24 weeks of gestation were 17\% (128/748) and 36\% (329/903), respectively; and of infants <500 g and 500 to 599 g at birth were 16\% (82/510) and 32\% (375/1145), respectively. None of the infants <==20 weeks of gestational age and <==350 g at birth survived, but 4\% (2/49), 12\% (27/218), 21\% (99/474), and 34\% (131/381) born at 21, 22, 23, and 24 weeks of gestation survived, respectively. The majority (68\%) died within 1 week after birth and only 10\% died after the neonatal period. The main causes of death were: acute respiratory failure (33\%), intraventricular hemorrhage (20\%), infection (16\%), and heart failure (10\%). Of 457 survivors, 65\% were free from handicaps. The incidence of mental retardation (DQ < 70), visual disturbance, and CP were 15\%, 14\%, and 11\%, respectively. Admission of micropremies to NICU increased markedly after the amendment of the Eugenic Protection Act, despite a marked decline in birth rate. The survival rate increased from 22\% to 33\% after generalized use of surfactant in 1988, but the handicap rate (35\%) among survivors remained unchanged. The new viability limit of 22 complete weeks of gestation was feasible, since survival of less than 22 weeks was exceptional while survival of 22 to 23 weeks was 18\%.
This article was published in Pediatrics and referenced in Journal of Health & Medical Informatics

Relevant Expert PPTs

Relevant Speaker PPTs

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords